EHD3
Basic information
Region (hg38): 2:31234152-31269451
Previous symbols: [ "PAST3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EHD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 0 | 3 |
Variants in EHD3
This is a list of pathogenic ClinVar variants found in the EHD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-31234637-G-T | not specified | Uncertain significance (Feb 21, 2024) | ||
2-31234655-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
2-31234711-G-C | not specified | Uncertain significance (Apr 22, 2022) | ||
2-31234713-G-C | not specified | Likely benign (Mar 30, 2024) | ||
2-31234742-C-A | not specified | Uncertain significance (Mar 30, 2024) | ||
2-31234743-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
2-31234796-C-T | not specified | Uncertain significance (Jun 03, 2024) | ||
2-31244339-T-A | not specified | Uncertain significance (Sep 17, 2021) | ||
2-31249477-C-T | Benign (May 08, 2018) | |||
2-31260519-T-C | not specified | Uncertain significance (Aug 09, 2021) | ||
2-31260652-A-G | Benign (May 08, 2018) | |||
2-31260787-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
2-31260856-G-T | not specified | Uncertain significance (May 23, 2024) | ||
2-31260876-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
2-31261588-C-T | not specified | Uncertain significance (May 29, 2024) | ||
2-31261600-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
2-31261611-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
2-31261618-A-C | not specified | Uncertain significance (Mar 29, 2023) | ||
2-31261663-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
2-31266202-G-C | not specified | Uncertain significance (Mar 29, 2024) | ||
2-31266206-G-C | not specified | Uncertain significance (Oct 14, 2023) | ||
2-31266258-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
2-31266265-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
2-31266307-G-A | not specified | Uncertain significance (Mar 03, 2022) | ||
2-31266333-G-T | not specified | Uncertain significance (Nov 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EHD3 | protein_coding | protein_coding | ENST00000322054 | 6 | 35434 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0422 | 0.957 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 241 | 335 | 0.720 | 0.0000200 | 3552 |
Missense in Polyphen | 55 | 90.023 | 0.61095 | 992 | ||
Synonymous | 0.0789 | 148 | 149 | 0.992 | 0.0000101 | 1053 |
Loss of Function | 2.86 | 6 | 19.7 | 0.305 | 0.00000101 | 216 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000231 | 0.000231 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000881 | 0.0000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis (PubMed:25686250). In vitro causes tubulation of endocytic membranes (PubMed:24019528). Binding to phosphatidic acid induces its membrane tubulation activity (By similarity). Plays a role in endocytic transport. Involved in early endosome to recycling endosome compartment (ERC), retrograde early endosome to Golgi, and endosome to plasma membrane (rapid recycling) protein transport. Involved in the regulation of Golgi maintenance and morphology (PubMed:16251358, PubMed:17233914, PubMed:19139087, PubMed:23781025). Involved in the recycling of internalized D1 dopamine receptor (PubMed:21791287). Plays a role in cardiac protein trafficking probably implicating ANK2 (PubMed:20489164). Involved in the ventricular membrane targeting of SLC8A1 and CACNA1C and probably the atrial membrane localization of CACNA1GG and CACNA1H implicated in the regulation of atrial myocyte excitability and cardiac conduction (By similarity). In conjunction with EHD4 may be involved in endocytic trafficking of KDR/VEGFR2 implicated in control of glomerular function (By similarity). Involved in the rapid recycling of integrin beta-3 implicated in cell adhesion maintenance (PubMed:23781025). Involved in the unidirectional retrograde dendritic transport of endocytosed BACE1 and in efficient sorting of BACE1 to axons implicating a function in neuronal APP processing (By similarity). Plays a role in the formation of the ciliary vesicle, an early step in cilium biogenesis; possibly sharing redundant functions with EHD1 (PubMed:25686250). {ECO:0000250|UniProtKB:Q9QXY6, ECO:0000269|PubMed:16251358, ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:19139087, ECO:0000269|PubMed:21791287, ECO:0000269|PubMed:23781025, ECO:0000269|PubMed:24019528, ECO:0000269|PubMed:25686250, ECO:0000305|PubMed:20489164}.;
- Pathway
- Endocytosis - Homo sapiens (human);Factors involved in megakaryocyte development and platelet production;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.139
- rvis_EVS
- -1.13
- rvis_percentile_EVS
- 6.48
Haploinsufficiency Scores
- pHI
- 0.158
- hipred
- Y
- hipred_score
- 0.672
- ghis
- 0.585
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.891
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ehd3
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- ehd3
- Affected structure
- neuromast hair cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- receptor recycling;blood coagulation;protein transport;endocytic recycling;early endosome to Golgi transport;protein homooligomerization;regulation of cardiac muscle contraction;cilium assembly;protein localization to plasma membrane;regulation of cardiac muscle cell membrane potential;Golgi to lysosome transport;positive regulation of voltage-gated calcium channel activity;regulation of Golgi organization;regulation of cardiac conduction
- Cellular component
- nucleus;cytoplasm;cytosol;focal adhesion;endosome membrane;ciliary pocket membrane;endocytic vesicle;myelin sheath;perinuclear region of cytoplasm;recycling endosome membrane
- Molecular function
- nucleic acid binding;calcium ion binding;protein binding;ATP binding;GTP binding